Search hospitals > Georgia > Atlanta

Emory University Hospital/Winship Cancer Institute

Claim this profile
Atlanta, Georgia 30322
Global Leader in Cancer
Global Leader in Tumors
Conducts research for Lymphoma
Conducts research for Breast Cancer
Conducts research for Multiple Myeloma
1082 reported clinical trials
101 medical researchers
Photo of Emory University Hospital/Winship Cancer Institute in AtlantaPhoto of Emory University Hospital/Winship Cancer Institute in AtlantaPhoto of Emory University Hospital/Winship Cancer Institute in Atlanta

Summary

Emory University Hospital/Winship Cancer Institute is a medical facility located in Atlanta, Georgia. This center is recognized for care of Cancer, Tumors, Lymphoma, Breast Cancer, Multiple Myeloma and other specialties. Emory University Hospital/Winship Cancer Institute is involved with conducting 1,082 clinical trials across 741 conditions. There are 101 research doctors associated with this hospital, such as Ticiana A. Leal, Edmund Waller, MD, Jonathan Cohen, MD, and Olatunji Alese.

Area of expertise

1Cancer
Global Leader
Emory University Hospital/Winship Cancer Institute has run 262 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Tumors
Global Leader
Emory University Hospital/Winship Cancer Institute has run 125 trials for Tumors. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at Emory University Hospital/Winship Cancer Institute

Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Prostate Cancer
Esophageal Carcinoma
Breast Cancer
Cancer
Lung Cancer
Gastric Cancer
Multiple Myeloma
Non-Small Cell Lung Cancer
Image of trial facility.

Proton Therapy vs Photon Radiation

for Esophageal Cancer

This trial studies how well proton beam radiation therapy compared with intensity modulated photon radiotherapy works in treating patients with stage I-IVA esophageal cancer. Proton beam radiation therapy uses a beam of protons (rather than x-rays) to send radiation inside the body to the tumor without damaging much of the healthy tissue around it. Intensity modulated photon radiotherapy uses high-energy x-rays to deliver radiation directly to the tumor without damaging much of the healthy tissue around it. It is not yet known whether proton beam therapy or intensity modulated photon radiotherapy will work better in treating patients with esophageal cancer.
Recruiting2 awards Phase 31 criteria
Image of trial facility.

Ramucirumab + Trifluridine/Tipiracil or Paclitaxel

for Gastric Cancer

This phase II trial studies the effect of the combination of ramucirumab and trifluridine/tipiracil or paclitaxel in treating patients with previously treated gastric or gastroesophageal junction cancer that has spread to other places in the body (advanced). Ramucirumab may damage tumor cells by targeting new blood vessel formation. Trifluridine/tipiracil is a chemotherapy pill and that may damage tumor cells by damaging their deoxyribonucleic acid (DNA). Paclitaxel may block cell growth by stopping cell division which may kill tumor cells. Giving ramucirumab and trifluridine/tipiracil will not be worse than ramucirumab and paclitaxel in treating gastric or gastroesophageal junction cancer.
Recruiting1 award Phase 21 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Emory University Hospital/Winship Cancer Institute?
Emory University Hospital/Winship Cancer Institute is a medical facility located in Atlanta, Georgia. This center is recognized for care of Cancer, Tumors, Lymphoma, Breast Cancer, Multiple Myeloma and other specialties. Emory University Hospital/Winship Cancer Institute is involved with conducting 1,082 clinical trials across 741 conditions. There are 101 research doctors associated with this hospital, such as Ticiana A. Leal, Edmund Waller, MD, Jonathan Cohen, MD, and Olatunji Alese.
Where is Emory University Hospital/Winship Cancer Institute located?
**Emory Winship Cancer Institute Location and Parking Information:** - **Address:** 1365 Clifton Road NE, Building B, Atlanta, Georgia, on the Emory University Hospital campus. - **Directions:** From I-85, take the North Avenue exit (Exit #249D), turn left on North Avenue, right onto Peachtree Street, and then right into the Visitor Parking Deck after passing Linden Avenue. - **Parking:** Valet parking and drop-off at 36 Linden Avenue NE. Onsite self-parking at 575 W Peachtree Street NW.
Who should I call to ask about financial aid or insurance network?
**Emory University Hospital/Winship Cancer Institute Financial Assistance:** - For financial assistance, including insurance coverage, out-of-pocket obligations, and locating financial coverage options, contact a Financial Counselor at (404) 778-7318. - For insurance department inquiries or general billing questions, call (404) 727-7551 and press 2.
What insurance does Emory University Hospital/Winship Cancer Institute accept?
Emory University Hospital/Winship Cancer Institute accepts most major insurance plans, including private and employer-based plans, Federal health insurance marketplace plans, traditional Medicare, and Medicare Advantage plans. They will file your insurance claims, both primary and secondary, and offer the services of a Financial Counselor, free of charge, to assist with the financial aspects of cancer treatment. For insurance or billing questions, please call (404) 778-7318, and for more information on accepted insurance plans, contact 404-778-7777 or 1-800-75-EMORY (1-800-753-6679).
What awards or recognition has Emory University Hospital/Winship Cancer Institute received?
Emory University Hospital and Winship Cancer Institute boast Magnet® recognition from the American Nurses Credentialing Center (ANCC), highlighting their excellence in nursing professionalism, teamwork, and patient care. The Emory University School of Medicine is renowned for its significant contributions to medical research, including Dr. Byron Au-Yeung's studies on T cell diversity and Dr. Cassandra Quave's ethnobotany research focusing on antibiotic properties.